Study to Gather Information About the Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following an Acute Heart Attack
Public ClinicalTrials.gov record NCT04304534. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Randomized, Placebo Controlled, Double-blind, Parallel Group, Dose-finding Phase 2 Study to Evaluate the Efficacy and Safety of BAY 2433334 in Patients Following an Acute Myocardial Infarction
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to try to find the best dose of the new drug BAY 2433334 to give to participants and to look at how well BAY 2433334 works on top of a dual antiplatelet therapy (acetylsalicylic acid +/- clopidogrel) in patients following a recent heart attack (myocardial infarction) that happens when a blood vessel in the heart suddenly becomes blocked. BAY 2433334, works by blocking a step of the blood clotting process in our body and thins the blood and is a so called oral FXIa inhibitor.
Study identification
- NCT ID
- NCT04304534
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 1,601 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 45 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 16, 2020
- Primary completion
- Feb 20, 2022
- Completion
- Feb 20, 2022
- Last update posted
- Apr 4, 2023
2020 – 2022
United States locations
- U.S. sites
- 22
- U.S. states
- 15
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Valley Clinical Trials, Inc. - Covina | Covina | California | 91723 | — |
| Florida Premier Cardiology | Boynton Beach | Florida | 33437 | — |
| Clearwater Cardiovascular Associates | Clearwater, FL | Clearwater | Florida | 33756 | — |
| Cardiology Associates Research Company | Daytona Beach | Florida | 32117 | — |
| Southwest Florida Research | Naples | Florida | 34102 | — |
| Cardiology Partners Clinical Research Institute | Palm Beach Gardens | Florida | 33410 | — |
| Columbus Regional Research Institute | Columbus | Georgia | 31904 | — |
| Reid Health | Richmond | Indiana | 47374 | — |
| Midwest Heart & Vascular Specialists | Overland Park | Kansas | 66211 | — |
| Cardiovascular Associates Research, LLC | Covington | Louisiana | 70433 | — |
| Southern Clinical Research, LLC | Zachary | Louisiana | 70791 | — |
| Maryland Cardiovascular Specialists | Baltimore | Maryland | 21229 | — |
| White Oak Medical Center | Silver Spring | Maryland | 20904 | — |
| St. Mary's/Duluth Clinic Health System | Duluth | Minnesota | 55805 | — |
| Logan Health Research | Kalispell | Montana | 59901 | — |
| Methodist Physicians Clinic | Omaha | Nebraska | 68114 | — |
| The Valley Hospital, Inc. | Ridgewood | New Jersey | 07450 | — |
| Trinity Medical WNY | Cheektowaga | New York | 14227 | — |
| Jefferson Heart Institute | Philadelphia | Pennsylvania | 19107 | — |
| Cardiovascular Research of Knoxville | Powell | Tennessee | 37849 | — |
| PharmaTex Research, LLC | Amarillo | Texas | 79109 | — |
| North Texas Research Associates | McKinney | Texas | 75071 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 138 non-U.S. sites.
Recently updated Acute Myocardial Infarction trials
Other public records listing Acute Myocardial Infarction. Sorted by last update posted; newest first. Not a recommendation.
- NCT05073419: Arrhythmia Detection After MI Recruiting
- NCT05800951: Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock Active, not recruiting
- NCT04743245: Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard. Recruiting
- NCT05185492: Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock Recruiting
- NCT04573660: Abbott Vascular Medical Device Registry Recruiting
- NCT05701358: Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04304534, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 4, 2023 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04304534 live on ClinicalTrials.gov.